[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336670-105":59,"doc-detail-336670-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","advancements-in-3d-in-vitro-models-for-colorectal-cancer-review-drug-discovery-and-pre-clinical-testing","Advancements in 3D In Vitro Models for Colorectal Cancer - Review - Drug Discovery and Pre-Clinical Testing","","Drug discovery and pre-clinical testing remain inefficient, costly, and slow, with an unsatisfactory success rate because few candidate drugs reach oncological patients. A major bottleneck is the lack of reliable models that accurately forecast efficacy and safety, since animal models may not reproduce human-specific pathologies and the complexity of the human body. The review highlights the need for human-relevant, translational 3D in vitro systems and explains how tumor microenvironment modeling can improve personalization and precision medicine in colorectal cancer.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/advancements-in-3d-in-vitro-models-for-colorectal-cancer-review-drug-discovery-and-pre-clinical-testing/336670/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/advancements-in-3d-in-vitro-models-for-colorectal-cancer-review-drug-discovery-and-pre-clinical-testing/336670.png","ImageObject",300,407,{"name":92,"@type":93},"Theodore","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why are current drug discovery and pre-clinical testing approaches inefficient for colorectal cancer?","Question",{"text":112,"@type":113},"They are described as time-consuming and expensive, with low success rates for drugs reaching patients. The text attributes this largely to insufficient predictive models for efficacy and safety.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does the tumor microenvironment (TME) influence colorectal cancer progression?",{"text":117,"@type":113},"The TME is portrayed as an interactive milieu that supports tumor development through mechanisms like metabolic reprogramming. It also helps drive tumor growth, radio/chemoresistance, invasion, and metastatic spread.",{"name":119,"@type":110,"acceptedAnswer":120},"What are the key advances enabling better 3D in vitro models for colorectal cancer?",{"text":121,"@type":113},"Recent progress in isolating and cultivating primary cells in 3D models and improvements in co-culture techniques enable patient-derived tissue models. These can incorporate increasing cell types and recreate physical tumor characteristics such as matrix composition, stiffness, and mechanical stimuli.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336670,1790148625,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},7971461740886,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","REVIEW  \n[www.advancedscience.com](www.advancedscience.com)  \nAdvancements in 3D In Vitro Models for Colorectal Cancer  \nSara Vitale, Federica Calapà, Francesca Colonna, Francesca Luongo, Mauro Biﬀoni, Ruggero De Maria,* and Micol E. Fiori*  \nThe process of drug discovery and pre-clinical testing is currently ineﬃcient, expensive, and time-consuming. Most importantly, the success rate is unsatisfactory, as only a small percentage of tested drugs are made available to oncological patients. This is largely due to the lack of reliable models that accurately predict drug eﬃcacy and safety. Even animal models often fail to replicate human-speciﬁc pathologies and human body’s complexity. These factors, along with ethical concerns regarding animal use, urge the development of suitable human-relevant, translational in vitro models.  \n1. Tumor Microenvironment (TME)  \nColorectal cancer is a heterogeneous disease, consisting of molecularly and clinically distinct subgroups, with diﬀering prognosis and response to therapy. In addition to the heterogeneity observed between diﬀerent CRC patients (referred to as intertumoral heterogeneity), involving genetic, histological and clinical variations, individual tumor masses encompass genetically and phenotypically diﬀerent cancer  \nAs tumors are highly complex, approaching the study of cancer cells’ biology without considering their interaction and co-evolution with surrounding tissues is short-sighted. Recent progress in isolating and cultivating primary cells in 3D models, and advancements in co-culture techniques, enable the generation of patient-derived tissue models that incorporate an increasing number of cell types from the tumor microenvironment. By integrating these models with state-of-the-art technologies, it becomes possible to recreate crucial physical characteristics of tumors, such as matrix composition, stiﬀness, and mechanical stimuli resembling blood circulation. This review discusses the latest advancements in 3D in vitro models for colorectal cancer, and how they will support the personalization of treatments and the implementation of precision medicine approaches.  \nS. Vitale, F. Colonna, M. Biﬀoni, M. E. Fiori  \nDepartment of Oncology and Molecular Medicine (OMM) Istituto Superiore di Sanità  \nViale Regina Elena 299, Rome 00161, Italy E-mail: micol.ﬁ[ori@iss.it](ori@iss.it)  \nF. Calapà, F. Luongo, R. De Maria  \nDipartimento di Medicina e Chirurgia traslazionale Università Cattolica del Sacro Cuore  \nLargo F. Vito 1, Rome Italy  \nE-mail: [ruggero.demaria@unicatt.it](ruggero.demaria@unicatt.it)  \nR. De Maria  \nFondazione Policlinico Universitario “A. Gemelli”– IRCCS Largo F. Vito 1, Rome Italy  \nThe ORCID identiﬁcation number(s) for the author(s) of this article  \ncan be found under [https://doi.org/10.1002/advs.202405084](https://doi.org/10.1002/advs.202405084)[ ](https://doi.org/10.1002/advs.202405084)© 2024 The Author(s). Advanced Science published by Wiley-VCH GmbH. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \nDOI: 10.1002/advs.202405084  \ncell populations, deﬁned by a hierarchical organization, clonal diversity and interactions with the TME or stroma (referred to as intratumoral heterogeneity – ITH) . [1,2] While genetic and epigenetic alterations are the main drivers of CRC initiation and progression, the interactions of tumor cells with the TME are also critical contributors. These interactions promote the activity of a subpopulation of cancer cells, namely Cancer Stem Cells (CSCs), responsible for tumor growth, survival, migration, and invasion. [2–5] The TME further sustains tumor development through metabolic reprogramming, providing nutrients and energy for cancer evolution, radio/chemoresistance and metastatic spread. [6]  \nThe TME is an interactive milieu surrounding tumour cells, comprising both non-cellu","cbCaisMUBlTVCmjH","https://ap.wps.com/l/cbCaisMUBlTVCmjH","pdf",5339087,25,"English","# Tumor Microenvironment (TME)\n## Heterogeneity and challenges in current models\n## Advances in 3D culture, co-culture, and patient-derived tissue models\n## Components of the TME: ECM and key cellular subtypes","[{\"question\":\"Why are current drug discovery and pre-clinical testing approaches inefficient for colorectal cancer?\",\"answer\":\"They are described as time-consuming and expensive, with low success rates for drugs reaching patients. The text attributes this largely to insufficient predictive models for efficacy and safety.\"},{\"question\":\"How does the tumor microenvironment (TME) influence colorectal cancer progression?\",\"answer\":\"The TME is portrayed as an interactive milieu that supports tumor development through mechanisms like metabolic reprogramming. It also helps drive tumor growth, radio/chemoresistance, invasion, and metastatic spread.\"},{\"question\":\"What are the key advances enabling better 3D in vitro models for colorectal cancer?\",\"answer\":\"Recent progress in isolating and cultivating primary cells in 3D models and improvements in co-culture techniques enable patient-derived tissue models. These can incorporate increasing cell types and recreate physical tumor characteristics such as matrix composition, stiffness, and mechanical stimuli.\"}]","Advancements in 3D In Vitro Models for Colorectal Cancer - Review - Drug Discovery and Pre-Clinical Testing | PDF",1790016116,63,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/193246dcffcc6ed4146228086466476c.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/efe26c574adf3e010348dee00327ef77.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/022f3cb06960961cbe2dc3582e92a2e3.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8249416afdc2aa346d60e158ceb4ca66.webp",980,1287]